Recent Developments in Federal Qui Tam, False Claims Act and Whistleblower Litigation

During the past five years there have been very dramatic increases in Federal False Claims Act and whistleblower litigation, whether measured by numbers and size of claims, size of settlements or size of judgments. For example, in the last fiscal year, there were $4.9 billion recoveries, of which $439 million went to whistleblowers who initiated such claims (known as qui tam plaintiffs). The claims spanned the pharmaceutical, health care, defense, government procurement, mortgage, financial, and educational industries.

Federal False Claims Act actions can arise from false claims submitted under federal programs, supply contracts, service agreements or other vendor arrangements. The Act provides such claims arising from retaliatory discharge. There are also many other state statutes with built in whistleblower claims. There are also other common law whistleblower and tort claims, such as defamation, wrongful termination in violation of public policy, and breach of contract.

In this national webinar, our experienced false claims act and whistleblower attorneys will cover recent developments in Federal False Claims Act issues that should be of great interest to executives, managers, in house counsel, and human resources executives, including the following:

• Recent developments under the Federal False Claims Act
   
• Defense issues under the Federal False Claims Act
   
• Remedies under the Federal False Claims Act
   
• Whistleblower claims under the Federal False Claims Act
   
• Whistleblower claims under Environmental, Health and Safety statutes
   
• Defending common law whistleblower claims 
   
• Pre-litigation in house response to whistleblower allegations